TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 20374673

Group type: EXPERIMENTAL
Intervention: Learning potential (LP) indices from a test‐train‐test version of a list‐learning task
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Test‐retest reliability and interrelatedness of LP indices
Number of subjects: 43
Study: 22360905

Group type: EXPERIMENTAL
Intervention: Triclosan-coated suture group (170 patients)
Number of subjects: 510

Group type: COMPARATOR
Intervention: Noncoated suture group (340 patients)
Number of subjects: 510
Study: 15988695

Group type: EXPERIMENTAL
Intervention: Hydrocortisone (12.5 mg/h IV)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Saline infusion
Number of subjects: 6
Study: 12663105

Group type: EXPERIMENTAL
Intervention: Bipolar electrodissection tonsillectomy (BET)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Cold dissection tonsillectomy (CDT)
Number of subjects: 60
Study: 9608969

Group type: EXPERIMENTAL
Intervention: Scheduled administration of acetaminophen (60 mg.kg-1.24h-1 orally, 90 mg.kg-1.24h-1 rectally)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Acetaminophen 'as needed' (control group)
Number of subjects: 40
Study: 7658599

Group type: EXPERIMENTAL
Intervention: 0.2 mg/kg recombinant human GH for 7 to 13 days
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 2787561

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 40

Group type: COMPARATOR
Intervention: Thiopental
Number of subjects: 40

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 40
Study: 791331

Group type: EXPERIMENTAL
Intervention: Labetalol
Number of subjects: 18

Group type: COMPARATOR
Intervention: Propranolol
Number of subjects: 18
Study: 31077729

Group type: EXPERIMENTAL
Intervention: Moderate-to-severe insight impairment
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Minimal insight impairment
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: No insight impairment
Number of subjects: 3
Study: 31138244

Group type: EXPERIMENTAL
Intervention: VRD + elotuzumab (B1 + B2)
Number of subjects: 564

Group type: COMPARATOR
Intervention: VRD (A1 + A2)
Number of subjects: 564
Study: 28475943

Group type: EXPERIMENTAL
Intervention: Motivational Interviewing Treatment Integrity coding system 4.2 (MITI 4.2)
Number of subjects: 22
Study: 25176939

Group type: EXPERIMENTAL
Intervention: Ferric carboxymaltose (FCM, n = 152)
Number of subjects: 304

Group type: COMPARATOR
Intervention: Placebo (saline, n = 152)
Number of subjects: 304
Study: 23260747

Group type: EXPERIMENTAL
Intervention: Canola protein isolate (CPI)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Canola protein hydrolyzate (CPH)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Soy protein isolate (SPI)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Nitrogen balance
Number of subjects: 28
Study: 21982529

Group type: EXPERIMENTAL
Intervention: Fluconazole 200 mg three times per week
Number of subjects: 1519

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1519

Group type: EXPERIMENTAL
Intervention: Fluconazole
Number of subjects: 1519
Study: 18496341

Group type: EXPERIMENTAL
Intervention: Bryan Disc arthroplasty
Number of subjects: 463

Group type: COMPARATOR
Intervention: Anterior cervical discectomy and fusion
Number of subjects: 463
Study: 16522388

Group type: EXPERIMENTAL
Intervention: Antibiotic group (oral azithromycin 1 g twice, plus metronidazole 750 mg daily for 7 days)
Number of subjects: 241

Group type: COMPARATOR
Intervention: Placebo group (identical-appearing placebos)
Number of subjects: 241
Study: 14661817

Group type: EXPERIMENTAL
Intervention: Training groups
Number of subjects: 203

Group type: COMPARATOR
Intervention: Control groups
Number of subjects: 203
Study: 10639034

Group type: EXPERIMENTAL
Intervention: 0.1 mmol Gd/kg (group 1)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: 0.3 mmol Gd/kg (group 1)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: 0.1 mmol Gd/kg (group 2)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: 0.3 mmol Gd/kg (group 2)
Number of subjects: 21
Study: 8699051

Group type: EXPERIMENTAL
Intervention: 40 mg of sorivudine
Number of subjects: 186

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 186
Study: 1526858

Group type: EXPERIMENTAL
Intervention: Daily treatment regimen delivering 2 Gy per fraction
Number of subjects: 203

Group type: COMPARATOR
Intervention: Once weekly treatment regimen delivering 5.4 Gy per fraction
Number of subjects: 203
Study: 3884122

Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide-amiloride hydrochloride (Moduret)
Number of subjects: 266

Group type: COMPARATOR
Intervention: Hydrochlorothiazide alone
Number of subjects: 266
Study: 29794092

Group type: EXPERIMENTAL
Intervention: Gelatine tannate (250-500 mg, four times per day for 5 days)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo (four times per day for 5 days)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Gelatine tannate
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study: 25489672

Group type: EXPERIMENTAL
Intervention: Laparoscopic lavage
Number of subjects: 83

Group type: COMPARATOR
Intervention: Hartmann procedure (Control)
Number of subjects: 83
Study: 24813026

Group type: EXPERIMENTAL
Intervention: Duloxetine (60‐120 mg once daily, n=117)
Number of subjects: 337

Group type: EXPERIMENTAL
Intervention: Fluoxetine (20‐40 mg once daily, n=117)
Number of subjects: 337

Group type: COMPARATOR
Intervention: Placebo (n=103)
Number of subjects: 337

Group type: EXPERIMENTAL
Intervention: Duloxetine
Number of subjects: 337

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 337

Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 337
Study: 22016361

Group type: EXPERIMENTAL
Intervention: Preventive home visit program (structured visits every 6 months for 2 years)
Number of subjects: 323

Group type: COMPARATOR
Intervention: Control group (no preventive home visits)
Number of subjects: 323
Study: 20033907

Group type: COMPARATOR
Intervention: Haloperidol
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: Atypical antipsychotics (risperidone, olanzapine, aripiprazole)
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: Aripiprazole
Number of subjects: 139
Study: 18753666

Group type: EXPERIMENTAL
Intervention: Pramlintide 120 microg t.i.d.
Number of subjects: 411

Group type: EXPERIMENTAL
Intervention: Pramlintide 360 microg b.i.d.
Number of subjects: 411

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 411
Study: 15354199

Group type: EXPERIMENTAL
Intervention: Very-low-protein diet supplemented with ketoacids (VLPD+KA)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Conventional low-protein diet (LPD)
Number of subjects: 24
Study: 12116051

Group type: EXPERIMENTAL
Intervention: Glyzide (Julphar, UAE)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Diamicron (Servier Industries, France)
Number of subjects: 24
Study: 10566499

Group type: EXPERIMENTAL
Intervention: Newton MessagePad outfitted with custom software (AsthMonitor) for documentation and guideline recommendations
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Recommendations provided by AsthMonitor
Number of subjects: 9
Study: 8567844

Group type: EXPERIMENTAL
Intervention: Combined leuprolide (3.75 mg every 27 days) plus conventional therapy (group A)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Conventional therapy alone (group B)
Number of subjects: 24

Group type: COMPARATOR
Intervention: GnRHa treatment (group C)
Number of subjects: 24
Study: 2358736

Group type: EXPERIMENTAL
Intervention: Infrared photocoagulation (IRC)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Conventional treatment (CT) by injection sclerotherapy or rubber band ligation
Number of subjects: 200

Group type: COMPARATOR
Intervention: Conventional treatment (CT)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Rubber band ligation (RBL)
Number of subjects: 200
Study: 526396

Group type: EXPERIMENTAL
Intervention: labetalol Css
Number of subjects: 17
Study: 30733143

Group type: EXPERIMENTAL
Intervention: Anodal tsDCS + BLT
Number of subjects: 43

Group type: COMPARATOR
Intervention: Sham tsDCS + BLT
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Both groups (Anodal tsDCS + BLT and Sham tsDCS + BLT)
Number of subjects: 43
Study: 27468907

Group type: EXPERIMENTAL
Intervention: Pose SM intervention (gastric fundus and distal body suture-anchor plications with diet/exercise counseling)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Pose SM intervention
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control (diet/exercise guidance only)
Number of subjects: 44
Study: 26383695

Group type: EXPERIMENTAL
Intervention: Interactive Behavioural Modification Therapy (IBMT)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Progressive Neck Exercise Programme (PNEP)
Number of subjects: 57
Study: 24126796

Group type: EXPERIMENTAL
Intervention: Log-transformed PORPUS-U without hierarchy constraint
Number of subjects: 676

Group type: EXPERIMENTAL
Intervention: Original PORPUS-U scores
Number of subjects: 676

Group type: EXPERIMENTAL
Intervention: Log-transformed PORPUS-U with hierarchy constraint
Number of subjects: 676

Group type: EXPERIMENTAL
Intervention: Mapping algorithm for calculating PORPUS-U from PCI scores
Number of subjects: 676
Study: 21788373

Group type: EXPERIMENTAL
Intervention: FTO rs17817449 genotype GG
Number of subjects: 1188

Group type: EXPERIMENTAL
Intervention: FTO rs17817449 genotype GT
Number of subjects: 1188

Group type: COMPARATOR
Intervention: Control group (TT genotype)
Number of subjects: 1188
Study: 19284932

Group type: EXPERIMENTAL
Intervention: Nortriptyline
Number of subjects: 70

Group type: COMPARATOR
Intervention: Sertraline
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Both interventions (Nortriptyline and Sertraline)
Number of subjects: 70
Study: 17542209

Group type: EXPERIMENTAL
Intervention: 5% sodium fluoride bioerodible resin
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: 5% sodium fluoride varnish
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control (untreated)
Number of subjects: 36
Study: 15855970

Group type: EXPERIMENTAL
Intervention: Light-induced fluorescence endoscopy (LIFE)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standard endoscopy (SE)
Number of subjects: 50
Study: 11932564

Group type: EXPERIMENTAL
Intervention: Aerobic exercise training program for 12 weeks at 65-70% of work capacity
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 25
Study: 9150811

Group type: EXPERIMENTAL
Intervention: Selegiline
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study: 8197035

Group type: EXPERIMENTAL
Intervention: Ketorolac tromethamine 10 mg
Number of subjects: 160

Group type: COMPARATOR
Intervention: Ibuprofen 400 mg plus paracetamol 325 mg
Number of subjects: 160

Group type: COMPARATOR
Intervention: Dextropropoxyphene 65 mg plus paracetamol 400 mg
Number of subjects: 160
Study: 3592300

Group type: COMPARATOR
Intervention: Propranolol (0.01, 0.02, 0.03, and 0.04 mg/kg IV)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Pindolol (0.001, 0.002, 0.003, and 0.004 mg/kg IV)
Number of subjects: 20
Study: 31358477

Group type: EXPERIMENTAL
Intervention: Testosterone (200 mg testosterone enanthate per week)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 29978417

Group type: EXPERIMENTAL
Intervention: Mindfulness-based intervention (MBI)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 82
Study: 27767947

Group type: EXPERIMENTAL
Intervention: Occupational therapy intervention
Number of subjects: 11

Group type: COMPARATOR
Intervention: Standard care intervention
Number of subjects: 11
Study: 25223181

Group type: EXPERIMENTAL
Intervention: Qingfei Peiyuan Micro‐pill (QPM)
Number of subjects: 141

Group type: COMPARATOR
Intervention: Control group (Western medicine only)
Number of subjects: 141
Study: 23610857

Group type: EXPERIMENTAL
Intervention: Wrist angulation at 30 degrees (Group 30)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Wrist angulation at 45 degrees (Group 45)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Wrist angulation at 60 degrees (Group 60)
Number of subjects: 60
Study: 19340466

Group type: EXPERIMENTAL
Intervention: Leaflet instruction group
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Demonstration group
Number of subjects: 99

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 99
Study: 18831737

Group type: EXPERIMENTAL
Intervention: Microscopy-based diagnosis (Arm-I)
Number of subjects: 3171

Group type: COMPARATOR
Intervention: Clinical algorithm only (Arm-II)
Number of subjects: 3171

Group type: COMPARATOR
Intervention: No training (Arm-III)
Number of subjects: 3171
Study: 15877221

Group type: EXPERIMENTAL
Intervention: Open kinetic chain (OKC) knee extensor resistance training
Number of subjects: 64

Group type: COMPARATOR
Intervention: Closed kinetic chain (CKC) knee extensor resistance training
Number of subjects: 64
Study: 15322960

Group type: EXPERIMENTAL
Intervention: Once-daily extended-release methylphenidate
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Twice-daily immediate-release methylphenidate
Number of subjects: 79

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 79
Study: 10636265

Group type: EXPERIMENTAL
Intervention: Fluvastatin
Number of subjects: 364

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 364
Study: 9301060

Group type: EXPERIMENTAL
Intervention: Superdirective processing
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Delay-and-sum beamforming
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cardioid microphone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Single omnidirectional microphone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Single directional microphone (cardioid response pattern)
Number of subjects: 0
Study: 7693770

Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 9

Group type: COMPARATOR
Intervention: Haloperidol
Number of subjects: 9
Study: 2994320

Group type: EXPERIMENTAL
Intervention: Preoperative radiotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Immediate surgery
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Preoperative chemotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Preoperative therapy (chemotherapy or radiotherapy)
Number of subjects: 0
Study: 3280589

Group type: EXPERIMENTAL
Intervention: Domperidone (DMP) administration
Number of subjects: 7
Study: 31433919

Group type: EXPERIMENTAL
Intervention: Serelaxin (30 μg per kilogram of body weight per day) for 48 hours
Number of subjects: 6545

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6545
Study: 27786603

Group type: EXPERIMENTAL
Intervention: Clopidogrel (18.75 mg/cat q24h for seven days)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 25394856

Group type: EXPERIMENTAL
Intervention: Glycine air‐powder system (SGA) adjuncted to professional oral hygiene (POH)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Professional oral hygiene (POH)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Both groups (SGA and POH)
Number of subjects: 30
Study: 22581270

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (n = 111)
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy
Number of subjects: 161
Study: 21736844

Group type: EXPERIMENTAL
Intervention: Lupin beverage (50 g glucose + 12.5 g fibre + 22 g protein)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Soya beverage (50 g glucose + 12.5 g fibre + 22 g protein)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Lupin beverage
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Soya beverage
Number of subjects: 24
Study: 20101858

Group type: EXPERIMENTAL
Intervention: High-dose misoprostol (maximum total dose 1400 g)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Low-dose misoprostol (maximum total dose 1400 g)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: High-dose misoprostol
Number of subjects: 60

Group type: COMPARATOR
Intervention: Low-dose misoprostol
Number of subjects: 60
Study: 16401666

Group type: EXPERIMENTAL
Intervention: Aripiprazole 30 mg/day
Number of subjects: 272

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 272

Group type: EXPERIMENTAL
Intervention: Aripiprazole
Number of subjects: 272
Study: 15551047

Group type: EXPERIMENTAL
Intervention: Losartan, 100 mg once daily
Number of subjects: 63
Study: 11269891

Group type: EXPERIMENTAL
Intervention: Octreotide
Number of subjects: 17

Group type: COMPARATOR
Intervention: Somatostatin
Number of subjects: 17
Study: 9422295

Group type: EXPERIMENTAL
Intervention: isoflurane/N2O
Number of subjects: 20

Group type: COMPARATOR
Intervention: isoflurane
Number of subjects: 20
Study: 8393058

Group type: EXPERIMENTAL
Intervention: Foscarnet 90 mg/kg/day infusion administered over 2 h
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Foscarnet 120 mg/kg/day infusion administered over 2 h
Number of subjects: 32
Study: 2883129

Group type: EXPERIMENTAL
Intervention: Terfenadine (H1 histamine receptor antagonist)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 29870736

Group type: EXPERIMENTAL
Intervention: pyrimethamine (50 mg qd) + sulfadiazine (1 g tid) with folinic acid
Number of subjects: 143

Group type: COMPARATOR
Intervention: spiramycin (1 g tid)
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: pyrimethamine + sulfadiazine
Number of subjects: 143

Group type: COMPARATOR
Intervention: spiramycin
Number of subjects: 143
Study: 27804255

Group type: EXPERIMENTAL
Intervention: Acceptance-based behavioral intervention (ABBI)
Number of subjects: 162

Group type: COMPARATOR
Intervention: Standard behavioral treatment (SBT)
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: ABBI
Number of subjects: 162

Group type: COMPARATOR
Intervention: SBT
Number of subjects: 162
Study: 25363170

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin drops
Number of subjects: 72

Group type: COMPARATOR
Intervention: Ciprofloxacin tablets
Number of subjects: 72
Study: 22850757

Group type: EXPERIMENTAL
Intervention: Static bike group
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Treadmill group
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 35
Study: 20822306

Group type: EXPERIMENTAL
Intervention: Spaced practice
Number of subjects: 0

Group type: COMPARATOR
Intervention: Massed practice
Number of subjects: 0
Study: 18417645

Group type: EXPERIMENTAL
Intervention: Intermittent Training (IT)
Number of subjects: 11
Study: 15911730

Group type: EXPERIMENTAL
Intervention: 10 mg of simvastatin plus 15 g of psyllium (Metamucil) daily
Number of subjects: 68

Group type: COMPARATOR
Intervention: 10 mg of simvastatin plus placebo
Number of subjects: 68

Group type: COMPARATOR
Intervention: 20 mg of simvastatin plus placebo
Number of subjects: 68
Study: 17986531

Group type: EXPERIMENTAL
Intervention: Swan-neck straight catheter (SNC)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Conventional straight catheter (CS)
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Swan-neck curled tip catheter (SNC)
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Swan-neck straight catheter (SNS)
Number of subjects: 93
Study: 10470630

Group type: EXPERIMENTAL
Intervention: 0.1% lidocaine
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: 0.2% lidocaine
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: 0.05% lidocaine
Number of subjects: 240

Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 240
Study: 8602988

Group type: EXPERIMENTAL
Intervention: rhEPO (2 x 300 U/kg) and parenteral iron (2 x 200mg) with a 72 h interval
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: rhEPO (2 x 300 U/kg) and parenteral iron (2 x 200mg) with a 24 h interval
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control group received parenteral iron only
Number of subjects: 15
Study: 1682147

Group type: EXPERIMENTAL
Intervention: Combined epidural analgesia and general anaesthesia (GAE group)
Number of subjects: 0

Group type: COMPARATOR
Intervention: General anaesthesia (GA group)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 0
Study: 7138047

Group type: EXPERIMENTAL
Intervention: Test substances applied under occlusion for one month
Number of subjects: 0

Group type: COMPARATOR
Intervention: Rabbit ear model test
Number of subjects: 0
Study: 29113955

Group type: EXPERIMENTAL
Intervention: Amantadine
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: Modafinil
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: Methylphenidate
Number of subjects: 136

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 136
Study: 27164866

Group type: EXPERIMENTAL
Intervention: CALM tool
Number of subjects: 0

Group type: COMPARATOR
Intervention: Manual version of CALM
Number of subjects: 0
Study: 24625805

Group type: EXPERIMENTAL
Intervention: Booster dose of inactivated EV71 vaccine (160 U, 320 U, and 640 U with adjuvant and 640 U without adjuvant)
Number of subjects: 773

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 773
Study: 22119179

Group type: EXPERIMENTAL
Intervention: Brief motivational interviewing
Number of subjects: 184

Group type: COMPARATOR
Intervention: Information-advice session
Number of subjects: 184
Study: 20188087

Group type: EXPERIMENTAL
Intervention: ADVIA Centaur assay
Number of subjects: 248
Study: 17657384

Group type: EXPERIMENTAL
Intervention: Gabapentin 300 mg
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study: 15830251

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 12058997

Group type: EXPERIMENTAL
Intervention: Polymyxin B immobilized fiber (PMX‐F) treatment
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 40

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 40

Group type: COMPARATOR
Intervention: Septic trauma patients before treatment
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Septic trauma patients after treatment
Number of subjects: 40

Group type: COMPARATOR
Intervention: All trauma patients
Number of subjects: 40
Study: 9862248

Group type: EXPERIMENTAL
Intervention: Enalapril 20 mg
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Losartan 50 mg
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10